These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8324933)

  • 1. Therapeutic activity of SK&F 105685, a novel azaspirane with suppressor-cell inducing activity.
    Badger AM; Swift BA
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S107-9. PubMed ID: 8324933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity.
    High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM
    J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of SK&F 105685, a novel suppressor cell-inducing compound, in the adjuvant arthritic rat.
    Badger AM; Swift BA; Bugelski PJ; High WB; DiMartino MJ; Greig R
    Br J Rheumatol; 1991; 30 Suppl 2():66-9. PubMed ID: 1825183
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610.
    Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM
    J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and functional analysis of rat bronchoalveolar macrophages containing chemically induced phospholipid inclusions.
    Waites CR; Bugelski PJ; Badger AM
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):316-21. PubMed ID: 7871542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of SK&F 105685 in rat adjuvant arthritis: prophylactic and therapeutic effects on disease parameter progression.
    Badger AM; Swift BA; Webb EF; Clark RK; Bugelski PJ; Griswold DE
    Int J Immunopharmacol; 1993 Apr; 15(3):343-52. PubMed ID: 8505147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes.
    Badger AM; Dimartino MJ; Talmadge JE; Picker DH; Schwartz DA; Dorman JW; Mirabelli CK; Hanna N
    Int J Immunopharmacol; 1989; 11(7):839-46. PubMed ID: 2532178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SK&F 105685, a novel anti-arthritic agent, on immune function in the dog.
    Kaplan JM; Badger AM; Ruggieri EV; Swift BA; Bugelski PJ
    Int J Immunopharmacol; 1993 Feb; 15(2):113-23. PubMed ID: 8468115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of non-specific suppressor cells and myeloregulatory effects of an immunomodulatory azaspirane, SK&F 105685.
    King AG; Olivera D; Talmadge JE; Badger AM
    Int J Immunopharmacol; 1991; 13(1):91-100. PubMed ID: 1827431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685.
    Badger AM; King AG; Talmadge JE; Schwartz DA; Picker DH; Mirabelli CK; Hanna N
    J Autoimmun; 1990 Aug; 3(4):485-500. PubMed ID: 2145847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate.
    Connolly KM; Stecher VJ; Danis E; Pruden DJ; LaBrie T
    Int J Immunopharmacol; 1988; 10(6):717-28. PubMed ID: 3143680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarthritic and immunoregulatory activity of spirogermanium.
    DiMartino MJ; Lee JC; Badger AM; Muirhead KA; Mirabelli CK; Hanna N
    J Pharmacol Exp Ther; 1986 Jan; 236(1):103-10. PubMed ID: 2934544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis.
    Kuncirova V; Ponist S; Mihalova D; Drafi F; Nosal R; Acquaviva A; Gardi C; Harmatha J; Hradkova I; Bauerova K
    Fundam Clin Pharmacol; 2014 Dec; 28(6):616-26. PubMed ID: 24920394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis.
    Williams AS; Camilleri JP; Amos N; Williams BD
    Clin Exp Immunol; 1995 Dec; 102(3):560-5. PubMed ID: 8536373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
    Kaplan JM; Badger AM; Ruggieri EV; Olivera DL; Newman-Tarr T; Bugelski PJ
    J Clin Lab Immunol; 1991 Dec; 36(4):49-58. PubMed ID: 1668843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
    Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis. Multiparameter analysis of disease magnetic resonance imaging and bone mineral density measurements.
    Bradbeer JN; Kapadia RD; Sarkar SK; Zhao H; Stroup GB; Swift BA; Rieman DJ; Badger AM
    Arthritis Rheum; 1996 Mar; 39(3):504-14. PubMed ID: 8607900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
    Suszko A; Obmińska-Mrukowicz B
    J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents.
    Badger AM; Schwartz DA; Picker DH; Dorman JW; Bradley FC; Cheeseman EN; DiMartino MJ; Hanna N; Mirabelli CK
    J Med Chem; 1990 Nov; 33(11):2963-70. PubMed ID: 2146392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs.
    Connolly KM; Stecher VJ; Danis E; Pruden DJ; LaBrie T
    Agents Actions; 1988 Aug; 25(1-2):94-105. PubMed ID: 3142230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.